Economic Outlook for Pharmaceutical Supply Chain is Positive With Growth Predicted for 2013 According to new Cold Chain IQ Report

Economic Outlook for Pharmaceutical Supply Chain is Positive With Growth Predicted for 2013 According to new Cold Chain IQ Report PR Newswire LONDON, November 28, 2012 LONDON, November 28, 2012 /PRNewswire/ -- In the face of shrinking R&D pipelines and restructuring at the major pharmaceutical organisations, ColdChainIQ.com conducted an industry wide study to determine the economic prospects of the industry. The results of the study have now been published in a 21 page special report entitled "Economy and Job Outlook Survey - Cold Chain Pharma in Recessionary Times." Despite current global economic uncertainty, professionals operating in the pharmaceutical and biotech supply chain are optimistic about their job prospects with growth predicted for 2013 and beyond. The survey research also revealed that over 71% of manufacturers of life science products and temperature control solution and service providers plan to invest in new technologies in the next 12 months to tackle their supply chain challenges and improve the efficiency of their operations. Furthermore, respondents were positive about the future with 84% of manufacturers believing their company was better prepared to cope if a recession occurs in 2013. Industry experts predict the biggest growth in temperature controlled pharmaceutical shipments will come from emerging markets. Much of this expected growth is attributed to China and India's growing importance in the global pharmaceutical industry is growing.